ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,711Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 393

$899K Total Retail Price of All Prescriptions

Rank: 5 out of 393

1,191 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
22% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 1,191 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

17% of this provider’s 1,191 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 17,803 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

15% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
LISINOPRIL 1,029 926 1 2
SIMVASTATIN 841 747 2 1
LEVOTHYROXINE SODIUM 739 670 3 3
OMEPRAZOLE 723 632 4 6
HYDROCODONE-ACETAMINOPHEN 720 585 S3 5 5
AMLODIPINE BESYLATE 635 595 6 4
METFORMIN HCL 626 533 7 7
METOPROLOL TARTRATE 518 466 8 9
ATENOLOL 445 403 9 13
ZOLPIDEM TARTRATE 408 324 10 11
FUROSEMIDE 370 324 11 8
LISINOPRIL-HYDROCHLOROTHIAZIDE 341 310 12 24
HYDROCHLOROTHIAZIDE 292 243 13 10
SERTRALINE HCL 289 239 14 28
WARFARIN SODIUM 276 216 15 17
GABAPENTIN 273 218 16 15
LOVASTATIN 273 248 16 14
AZITHROMYCIN 256 227 18 35
ALENDRONATE SODIUM 219 212 19 16
PRAVASTATIN SODIUM 216 175 20 18
LOSARTAN POTASSIUM 197 191 21 12
ALLOPURINOL 195 169 22 26
CARVEDILOL 186 158 23 21
GLIMEPIRIDE 185 155 24 39
TAMSULOSIN HCL 175 168 25 25
RANITIDINE HCL 169 143 26 29
TRAMADOL HCL 165 130 27 30
TERAZOSIN HCL 158 154 28 38
KLOR-CON M20 157 145 29 137
PAROXETINE HCL 156 148 30 61
TRAZODONE HCL 154 81 31 47
CLOPIDOGREL 151 135 32 33
CITALOPRAM HBR 150 116 33 23
MELOXICAM 148 111 34 58
POTASSIUM CHLORIDE 148 125 34 20
ATORVASTATIN CALCIUM 146 124 36 19
OXYCODONE HCL-ACETAMINOPHEN 141 116 S2 37 54
PREDNISONE 134 121 38 65
CLONIDINE HCL 129 106 39 50
FLUOXETINE HCL 128 112 40 37
GLYBURIDE 119 115 R 41 46
TRIAMTERENE-HCTZ 118 101 42 49
METOPROLOL SUCCINATE 115 96 43 22
PLAVIX 113 107 44 51
VENTOLIN HFA 112 89 45 42
GEMFIBROZIL 111 103 46 62
OXYCODONE-ACETAMINOPHEN 103 70 S2 47 71
CIPROFLOXACIN HCL 102 92 48 57
FLUTICASONE PROPIONATE 102 84 48 27
FENOFIBRATE 100 58 50 43
RISPERIDONE 100 73 50 75
OXYBUTYNIN CHLORIDE 100 86 50 90
NAMENDA 98 89 53 59
BUPROPION HCL SR 98 79 53 181
OXYCODONE HCL 94 61 S2 55 36
SPIRIVA 92 83 56 41
DOXAZOSIN MESYLATE 87 82 57 83
FINASTERIDE 85 85 58 60
DIGOXIN 82 75 59 66
ADVAIR DISKUS 82 78 59 53
AMITRIPTYLINE HCL 82 65 R 59 72
ROPINIROLE HCL 82 74 59 121
CEPHALEXIN 80 75 63 131
ESTRADIOL 78 65 R 64 93
TRIAMCINOLONE ACETONIDE 75 70 65 94
METHYLPREDNISOLONE 74 65 66 80
LANTUS 74 50 66 73
IBUPROFEN 65 45 68 55
DOXYCYCLINE HYCLATE 65 55 68 146
METHOTREXATE 65 58 68 177
CARISOPRODOL 64 39 R 71 45
PROAIR HFA 64 60 71 68
DILTIAZEM ER 63 62 73 107
GLYBURIDE-METFORMIN HCL 61 52 R 74 125
GLIPIZIDE 61 60 74 32
VERAPAMIL ER 60 56 76 86
LANTUS SOLOSTAR 60 51 76 74
CARBIDOPA-LEVODOPA 60 46 76 142
FENTANYL 59 35 S2 79 135
MIRTAZAPINE 59 34 79 89
LOSARTAN-HYDROCHLOROTHIAZIDE 58 55 81 31
SPIRONOLACTONE 58 42 81 82
BETAMETHASONE DIPROPIONATE 56 50 83 287
QUETIAPINE FUMARATE 56 39 83 104
VENLAFAXINE HCL ER 55 45 85 177
MEGESTROL ACETATE 54 54 R 86 182
DONEPEZIL HCL 54 54 86 34
SYMBICORT 50 50 88 96
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 3, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.